bioAffinity Technologies (BIAF) Earnings Date & Reports
bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
BIAF is expected to report earnings to fall 10.53% to -17 cents per share on May 20
Q1'25
Est.
$-0.17
Q4'24
Missed
by $0.05
Q3'24
Missed
by $0.01
Q2'24
Missed
by $0.02
Q1'24
Missed
by $0.02
The last earnings report on March 31 showed earnings per share of -18 cents, missing the estimate of -14 cents. With 7.66M shares outstanding, the current market capitalization sits at 23.27M.